Skip to main content
. 2013 Feb 26;13:105. doi: 10.1186/1471-2334-13-105

Figure 3.

Figure 3

Cumulative incidence graph comparing therapy response with therapeutic versus subtherapeutic initial drug levels shows no statistically significant difference in complete or partial response to therapy at 12 weeks among a subset of patients with proven or probable invasive fungal disease (n = 46; HR: 0.45; P= 0.07).